Home » Topics » BioWorld Science

BioWorld Science
RSS

Chengdu Huajian Future Technology patents IDO-1 inhibitors

July 11, 2019

New PD-1/PD-L1 interaction inhibitors described by Yangtze River, Shanghai Haiyan

July 11, 2019

Chiesi discovers Rho kinase inhibitors

July 11, 2019

Guangdong Newopp Biopharmaceuticals presents new arginase inhibitors

July 11, 2019

Researchers develop CRISPR/Cas9 hemophilia A murine model

July 11, 2019

First patient dosed in phase II study of KD-025 in cutaneous systemic sclerosis

July 11, 2019

FDA clears Syndax's IND for phase I/II trial of SNDX-5613 for relapsed/refractory acute leukemias

July 11, 2019

Preclinical evaluation of enzymatically cleavable lipoglycopeptides for pulmonary MRSA

July 11, 2019

New vaccine protects nonhuman primates against equine encephalitis viruses

July 11, 2019

Preclearance boosts immunotherapy in pancreatic cancer

July 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...